Vyhláška, kterou se mění vyhláška č. 532/2005 Sb., o úhradách léčiv a potravin pro zvláštní lékařské účely
| 75 | beta-blokátory, ostatní cesty aplikace | ||||||
|---|---|---|---|---|---|---|---|
| 75.1 | C07AA | metipranolol | parent. | 10.00 | MG | 61,54 | O |
| 85886 | TRIMEPRANOL | inj 10x1ml/1mg | HBS | SK | |||
| --- | --- | --- | --- | --- | |||
| 75.2 | C07AG01 | labetalol | parent. | 0.60 | GM | 1 004,27 | H |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 75.3 | C07AA | talinolol | parent. | 50.00 | MG | 91,52 | O |
| 75.4 | C07AA02 | oxprenolol | parent. | 0.10 | GM | 96,88 | O |
| 75.5 | C07AA03 | pindolol | parent. | 15.00 | MG | 96,88 | O |
| 75.6 | C07AA07 | sotalol | parent. | 0.16 | GM | 880,20 | O |
| 75.7 | C07AB02 | metoprolol | parent. | 0.15 | GM | 1 366,44 | O |
| 75.8 | C07AB03 | atenolol | parent. | 75.00 | MG | 1 799,04 | O |
| 75.9 | C07AB04 | acebutolol | parent. | 0.40 | GM | 1 366,44 | O |
| 75.10 | C07AB09 | esmolol | parent. | 2.50 | GM | 4 109,55 | O |
| 76 | kombinace beta-blokátorů s jinými antihypertenzivy | ||||||
| 76.1 | C07BB03 | atenolol a thiazidy | p.o. | 1.00 | DF | 4,31 | |
| 76715 | TENORETIC | por tbl flm 28 | AZC | GB | |||
| --- | --- | --- | --- | --- | |||
| 76.2 | C07BB07 | bisoprolol a thiazidy | p.o. | 1.00 | DF | 3,63 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 76.3 | C07CA17 | bopindolol a thiazidy | p.o. | 1.00 | DF | 4,31 | |
| 76.4 | C07FA | beta-blokátory, neselektivní, a jiná antihypertensiva | p.o. | 0.50 | DF | 0,71 | |
| 77 | blokátory vápníkového kanálu ze skupiny dihydropyridinů, perorální podání | ||||||
| 77.1 | C08CA01 | amlodipin do 5 mg v 1 tbl včetně | p.o. | 5.00 | MG | 4,89 | |
| 02945 | AGEN 5 | por tbl nob 30x5mg | ZEH | CZ | |||
| --- | --- | --- | --- | --- | |||
| 03936 | AMLOPP-5 | por tbl nob 30x5mg | SDD | CZ | |||
| 03993 | NORMODIPINE 5 MG | por tbl nob 30x5mg | GED | H | |||
| 03998 | CARDILOPIN 5 MG | por tbl nob 30x5mg | EGI | H | |||
| 13464 | ORCAL 5 MG | por tbl nob90x5mg | LEK | SLO | |||
| 15378 | AGEN 5 | por tbl nob 90x5mg | ZEH | CZ | |||
| 19440 | ORCAL 5 MG TABLETY | por tbl nob30x5mg | LSW | PL | |||
| 19444 | ORCAL 5 MG TABLETY | por tbl nob90x5mg | LSW | PL | |||
| 32924 | ZOREM 5 MG | por tbl nob 30x5mg | PVL | CZ | |||
| 42833 | AMLODIPIN-RATIOPHARM 5 MG | por tbl nob 30x5mg | MCK | D | |||
| 42837 | AMLODIPIN-RATIOPHARM 5 MG | por tbl nob 100x5mg | MCK | D | |||
| 42848 | HIPRES 5 | por tbl nob 30x5mg | KRK | SLO | |||
| 58415 | ORCAL 5MG | tbl 30x5mg | LEK | SLO | |||
| 58874 | AMLOZEK 5 | por tbl nob 30x5mg | ADD | PL | |||
| 95582 | ZOREM 5 MG | por tbl nob 100x5mg | PVL | CZ | |||
| 77.2 | C08CA01 | amlodipin nad 5 mg v 1 tbl | p.o. | 5.00 | MG | 3,91 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 02954 | AGEN 10 | por tbl nob 30x10mg | ZEH | CZ | |||
| --- | --- | --- | --- | --- | |||
| 03944 | AMLOPP-10 | por tbl nob 30x10mg | SDD | CZ | |||
| 03999 | CARDILOPIN 10 MG | por tbl nob 30x10mg | EGI | H | |||
| 13466 | ORCAL 10 MG | por tbl nob90x10mg | LEK | SLO | |||
| 13851 | AMLODIPIN-RATIOPHARM 10 MG | por tbl nob 30x10mg | MCK | D | |||
| 13852 | AMLODIPIN-RATIOPHARM 10 MG | por tbl nob100x10mg | MCK | D | |||
| 15379 | AGEN 10 | por tbl nob 90x10mg | ZEH | CZ | |||
| 19442 | ORCAL 10 MG TABLETY | por tbl nob30x10mg | LSW | PL | |||
| 19446 | ORCAL 10 MG TABLETY | por tbl nob90x10mg | LSW | PL | |||
| 42849 | HIPRES 10 | por tbl nob 30x10mg | KRK | SLO | |||
| 58417 | ORCAL 10MG | tbl 30x10mg | LEK | SLO | |||
| 58876 | AMLOZEK 10 | por tbl nob 30x10mg | ADD | PL | |||
| 77.3 | C08CA02 | felodipin do 5 mg v 1 tbl včetně | p.o. | 5.00 | MG | 4,89 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 02957 | PRESID 5 MG | por tbl ret 30x5mg | IXP | CZ | |||
| --- | --- | --- | --- | --- | |||
| 02961 | PRESID 2.5 MG | por tbl ret30x2.5mg | IXP | CZ | |||
| 20394 | FELODIPIN-RATIOPHARM 5 MG | por tbl pro 30x5mg | MCK | D | |||
| 20397 | FELODIPIN-RATIOPHARM 5 MG | por tbl pro100x5mg | MCK | D | |||
| 21534 | FELOCOR 5 | por tbl pro 30x5mg | SFS | D | |||
| 21548 | FELOCOR 5 | por tbl pro 30x5mg | HED | DK | |||
| 42942 | FELODIPIN AL 5 RETARD | por tbl ret 30x5mg | APA | D | |||
| 48584 | FELOCOR 5 | por tbl pro 30x5mg | SFS | D | |||
| 48595 | FELOCOR 5 | por tbl pro 30x5mg | HED | DK | |||
| 77.4 | C08CA02 | felodipin nad 5 mg v 1 tbl | p.o. | 5.00 | MG | 3,91 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 02959 | PRESID 10 MG | por tbl ret 30x10mg | IXP | CZ | |||
| --- | --- | --- | --- | --- | |||
| 20317 | FELODIPIN-RATIOPHARM 10 MG | por tbl pro 30x10mg | MCK | D | |||
| 20320 | FELODIPIN-RATIOPHARM 10 MG | por tbl pro100x10mg | MCK | D | |||
| 21504 | FELOCOR 10 | por tbl pro 30x10mg | SFS | D | |||
| 21519 | FELOCOR 10 | por tbl pro 30x10mg | HED | DK | |||
| 42946 | FELODIPIN AL 10 RETARD | por tbl ret 30x10mg | APA | D | |||
| 48608 | FELOCOR 10 | por tbl pro 30x10mg | SFS | D | |||
| 48619 | FELOCOR 10 | por tbl pro 30x10mg | HED | DK | |||
| 77.5 | C08CA03 | Isradipin | p.o. | 5.00 | MG | 4,64 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 77.6 | C08CA03 | isradipin (retardované lékové formy) | p.o. | 5.00 | MG | 4,89 | |
| 77.7 | C08CA05 | nifedipin | p.o. | 30.00 | MG | 1,42 | |
| 77.8 | C08CA05 | nifedipin (lékové formy s retardací 24 hodin) | p.o. | 1.00 | DF | 4,89 | |
| 03033 | CORDIPIN XL | tbl ret 30x40mg | KRK | SLO | |||
| --- | --- | --- | --- | --- | |||
| 53372 | NIFECARD XL 30MG | tbl ret 30x30mg | LEK | SLO | |||
| 77.9 | C08CA05 | nifedipin (retardované lékové formy s obsahem 20 mg) | p.o. | 30.00 | MG | 1,98 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 47490 | CORINFAR 20 RETARD | por tbl pro 30x20mg | AWD | D | |||
| --- | --- | --- | --- | --- | |||
| 93460 | CORDIPIN RETARD | tbl ret 30x20mg | KRK | SLO | |||
| 77.10 | C08CA05 | nifedipin (retardované lékové formy s obsahem 40 mg) | p.o. | 30.00 | MG | 1,34 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 77.11 | C08CA06 | nimodipin | p.o. | 0.30 | GM | 132,99 | X |
| 94189 | DILCEREN | tbl obd 50x30mg | ZEH | SK | |||
| --- | --- | --- | --- | --- | |||
| 77.12 | C08CA07 | nisoldipin | p.o. | 20.00 | MG | 4,89 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 77.13 | C08CA08 | nitrendipin | p.o. | 20.00 | MG | 4,89 | |
| 03078 | UNIPRES 20 | tbl 30x20mg | KRK | SLO | |||
| --- | --- | --- | --- | --- | |||
| 03079 | UNIPRES 10 | tbl 30x10mg | KRK | SLO | |||
| 30965 | NITRENDIPIN-RATIOPHARM 20MG | por tbl nob100x20mg | MCK | D | |||
| 66469 | NITREPRESS 10 | por tbl nob 20x10mg | HHO | D | |||
| 66495 | NITREPRESS 10 | por tbl nob 50x10mg | HHO | D | |||
| 66498 | NITREPRESS 20 | por tbl nob 50x20mg | HHO | D | |||
| 66499 | NITREPRESS 20 | por tbl nob 20x20mg | HHO | D | |||
| 94688 | NITRENDIPIN-RATIOPHARM 20MG | por tbl nob 30x20mg | MCK | D | |||
| 95584 | NITREPRESS 10 | por tbl nob 28x10mg | HHO | D | |||
| 95586 | NITREPRESS 20 | por tbl nob 28x20mg | HHO | D | |||
| 77.14 | C08CA09 | lacidipin | p.o. | 4.00 | MG | 4,89 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 77.15 | C08CA10 | nilvadipin do 8 mg v 1 tbl včetně | p.o. | 8.00 | MG | 4,89 | |
| 77.16 | C08CA10 | nilvadipin nad 8 mg v 1 tbl | p.o. | 8.00 | MG | 3,91 | |
| 77.17 | C08CA12 | barnidipin do 10 mg v 1 tbl včetně | p.o. | 10.00 | MG | 4,89 | |
| 77.18 | C08CA12 | barnidipin nad 10 mg v 1 tbl | p.o. | 10.00 | MG | 3,91 | |
| 77.19 | C08CA13 | lercanidipin | p.o. | 10.00 | MG | 4,89 | |
| 78 | blokátory vápníkových kanálů ostatních skupin, perorální podání | ||||||
| 78.1 | C08DA01 | verapamil (retardované lékové formy s obsahem 240 mg v jedné tabletě včetně) | p.o. | 0.24 | GM | 4,89 | |
| 43879 | VEROGALID ER 240 MG | portblpro 100x240mg | IXP | CZ | |||
| --- | --- | --- | --- | --- | |||
| 54032 | VERAPAMIL AL 240 RETARD | por tbl ret50x240mg | APA | D | |||
| 54034 | VERAPAMIL AL 240 RETARD | por tblret100x240mg | APA | D | |||
| 56164 | VERAHEXAL RR | tbl ret 30x240mg | FST | D | |||
| 56165 | VERAHEXAL RR | tbl ret 50x240mg | FST | D | |||
| 56166 | VERAHEXAL RR | tbl ret 100x240mg | FST | D | |||
| 93679 | LEKOPTIN RETARD | tbl ret 20x240mg | LEK | SLO | |||
| 99575 | VEROGALID ER 240 MG | por tblpro30x240mg | IXP | CZ | |||
| 78.2 | C08DA01 | verapamil neretardované lékové formy do 240 mg v jedné tabletě včetně | p.o. | 0.24 | GM | 4,40 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 17841 | VERAHEXAL 120 | portblflm30x120mg | HPZ | PL | |||
| --- | --- | --- | --- | --- | |||
| 17842 | VERAHEXAL 120 | portblflm 50x120mg | HPZ | PL | |||
| 17843 | VERAHEXAL 120 | portblflm 100x120mg | HPZ | PL | |||
| 17844 | VERAHEXAL 80 | portblflm 30x80mg | HPZ | PL | |||
| 56152 | VERAHEXAL 40 | tbl obd 30x40mg | FST | D | |||
| 56155 | VERAHEXAL 80 | tbl obd 30x80mg | FST | D | |||
| 56158 | VERAHEXAL 120 | tbl obd 30x120mg | FST | D | |||
| 56159 | VERAHEXAL 120 | tbl obd 50x120mg | FST | D | |||
| 56160 | VERAHEXAL 120 | tbl obd 100x120mg | FST | D | |||
| 56161 | VERAHEXAL KHK RETARD | tbl ret 30x120mg | FST | D | |||
| 56162 | VERAHEXAL KHK RETARD | tbl ret 50x120mg | FST | D | |||
| 56163 | VERAHEXAL KHK RETARD | tbl ret 100x120mg | FST | D | |||
| 77037 | VERAPAMIL AL 80 | por tblflm100x80mg | APA | D | |||
| 86046 | VERAPAMIL AL 120 | por tblflm 100x120mg | APA | D | |||
| 78.3 | C08DA02 | gallopamil | p.o. | 0.10 | GM | 4,40 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 78.4 | C08DB01 | diltiazem | p.o. | 0.24 | GM | 4,64 | |
| 78.5 | C08DB01 | diltiazem (retardované lékové formy s obsahem 120 mg a více) | p.o. | 0.24 | GM | 4,89 | |
| 79 | blokátory vápníkových kanálů, ostatní cesty aplikace | ||||||
| 79.1 | C08CA03 | isradipin | parent. | 5.00 | MG | 3 004,80 | H |
| 79.2 | C08CA05 | nifedipin | parent. | 30.00 | MG | 3 004,80 | H |
| 79.3 | C08CA06 | nimodipin | parent. | 50.00 | MG | 2 950,65 | X |
| 94535 | NIMOTOP S | inf sol 5x50ml/10mg | BAY | D | |||
| --- | --- | --- | --- | --- | |||
| 79.4 | C08DA01 | verapamil | parent. | 0.24 | GM | 347,18 | H |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 79.5 | C08DB01 | diltiazem | parent. | 25.00 | MG | 324,53 | H |
| 80 | ACE inhibitory působící méně než 24 hodin | ||||||
| 80.1 | C09AA01 | kaptopril (do 12,5 mg v 1 tabletě včetně) | p.o. | 50.00 | MG | 3,81 | |
| 15327 | APO-CAPTO 12.5 MG | tbl 100x12.5mg | CMG | IRL | |||
| --- | --- | --- | --- | --- | |||
| 16564 | APO-CAPTO 12.5 MG | tbl 100x12.5mg | KAT | NL | |||
| 96903 | APO-CAPTO 12.5 MG | tbl 100x12.5mg | APT | CND | |||
| 80.2 | C09AA01 | kaptopril (nad 12,5 mg do 25 mg v 1 tabletě včetně) | p.o. | 50.00 | MG | 3,52 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 15326 | APO-CAPTO 25 MG | tbl 100x25mg | CMG | IRL | |||
| --- | --- | --- | --- | --- | |||
| 16563 | APO-CAPTO 25 MG | tbl 100x25mg | KAT | NL | |||
| 68839 | APO-CAPTO 25 MG | tbl 100x25mg | APT | CND | |||
| 80.3 | C09AA01 | kaptopril (nad 25 mg v 1 tabletě) | p.o. | 50.00 | MG | 3,32 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 80.4 | C09AA02 | enalapril hydrogenmaleát (do 5 mg v jedné tabletě včetně) | p.o. | 10.00 | MG | 3,91 | |
| 20419 | ENALAPRIL AL 5 | por tbl nob 100x5mg | APA | D | |||
| --- | --- | --- | --- | --- | |||
| 32758 | ENALEK 5 MG | por tbl nob 30x5mg | LEK | SLO | |||
| 59879 | ENAPRIL 5 | tbl 100x5mg | SFS | D | |||
| 80.5 | C09AA02 | enalapril hydrogenmaleát (nad 10 mg v jedné tabletě) | p.o. | 10.00 | MG | 2,25 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 32760 | ENALEK 20 MG | por tbl nob 30x20mg | LEK | SLO | |||
| --- | --- | --- | --- | --- | |||
| 80.6 | C09AA02 | enalapril hydrogenmaleát (nad 5 do 10 mg v jedné tabletě včetně) | p.o. | 10.00 | MG | 3,23 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 20422 | ENALAPRIL AL 10 | por tbl nob100x10mg | APA | D | |||
| --- | --- | --- | --- | --- | |||
| 32759 | ENALEK 10 MG | por tbl nob 30x10mg | LEK | SLO | |||
| 80.7 | C09AA02 | enalaprilát | parent. | 1.25 | MG | 23,84 | H |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 62597 | ENAP I.V. | inj 5x1ml/1.25mg | KRK | SLO | |||
| --- | --- | --- | --- | --- | |||
| 81 | ostatní ACE-inhibitory | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 81.1 | C09AA03 | lisinopril | p.o. | 10.00 | MG | 4,40 | |
| 10625 | LISINOPRIL-RATIOPHARM 5 MG | por tbl nob 30x5mg | MCK | D | |||
| --- | --- | --- | --- | --- | |||
| 10629 | LISINOPRIL-RATIOPHARM 5 MG | por tbl nob 100x5mg | MCK | D | |||
| 10683 | LISINOPRIL-RATIOPHARM 10 MG | por tbl nob 30x10mg | MCK | D | |||
| 10685 | LISINOPRIL-RATIOPHARM 10 MG | por tbl nob100x10mg | MCK | D | |||
| 10884 | LISINOPRIL-RATIOPHARM 20 MG | por tbl nob30x20mg | MCK | D | |||
| 11006 | DIROTON 10 MG | tbl 100x10mg | GED | H | |||
| 32501 | DAPRIL 5 | por tbl nob 100x5mg | MOE | CY | |||
| 32503 | DAPRIL 10 | por tbl nob100x10mg | MOE | CY | |||
| 32505 | DAPRIL 20 | por tbl nob 60x20mg | MOE | CY | |||
| 95657 | LISIPRIL 5 | por tbl nob 30x5mg | SFS | D | |||
| 95665 | LISIPRIL 10 | por tbl nob 30x10mg | SFS | D | |||
| 95673 | LISIPRIL 20 | por tbl nob 30x20mg | SFS | D | |||
| 81.2 | C09AA04 | perindopril do 4 mg v 1 tbl včetně | p.o. | 4.00 | MG | 5,40 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 81.3 | C09AA04 | perindopril nad 4 mg v 1 tbl | p.o. | 4.00 | MG | 3,78 | |
| 81.4 | C09AA05 | ramipril do 2,5 mg v jedné tabletě včetně | p.o. | 2.50 | MG | 5,40 | |
| 01436 | PIRAMIL 1.25 MG | por tblnob30x1.25mg | LSW | PL | |||
| --- | --- | --- | --- | --- | |||
| 01444 | PIRAMIL 1.25 MG | portblnob100x1.25mg | LSW | PL | |||
| 01544 | PIRAMIL 2.5 MG | por tbl nob30x2.5mg | LSW | PL | |||
| 01564 | PIRAMIL 2.5 MG | por tblnob100x2.5mg | LSW | PL | |||
| 13469 | RAMIL 1.25 | por tblnob30x1.25mg | ZEH | CZ | |||
| 13470 | RAMIL 1.25 | por tblnob90x1.25mg | ZEH | CZ | |||
| 13472 | RAMIL 2.5 | por tblnob 30x2.5mg | ZEH | CZ | |||
| 13473 | RAMIL 2.5 | por tblnob 90x2.5mg | ZEH | CZ | |||
| 16405 | PIRAMIL 1.25 MG | por tblnob30x1.25mg | SZP | D | |||
| 16407 | PIRAMIL 1.25 MG | portblnob100x1.25mg | SZP | D | |||
| 16420 | PIRAMIL 2.5 MG | por tbl nob30x2.5mg | SZP | D | |||
| 16422 | PIRAMIL 2.5 MG | por tblnob100x2.5mg | SZP | D | |||
| 18668 | RAMILIFE 2.5 MG | por tbl nob30x2.5mg | AHJ | IS | |||
| 23954 | AMPRILAN 1.25 | portblnob 30x1.25mg | KRK | SLO | |||
| 23956 | AMPRILAN 1.25 | portblnob 60x1.25mg | KRK | SLO | |||
| 23957 | AMPRILAN 1.25 | portblnob 90x1.25mg | KRK | SLO | |||
| 23958 | AMPRILAN 2.5 | portbl nob 30x2.5mg | KRK | SLO | |||
| 23960 | AMPRILAN 2.5 | portbl nob 60x2.5mg | KRK | SLO | |||
| 23961 | AMPRILAN 2.5 | portbl nob 90x2.5mg | KRK | SLO | |||
| 48752 | HARTIL 1.25 MG | portblnob 28x1.25mg | EGI | H | |||
| 48753 | HARTIL 2.5 MG | portblnob 28x2.5mg | EGI | H | |||
| 81.5 | C09AA05 | ramipril nad 2,5 mg do 5 mg v jedné tabletě včetně | p.o. | 2.50 | MG | 3,78 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01874 | PIRAMIL 5 MG | por tbl nob 30x5mg | LSW | PL | |||
| --- | --- | --- | --- | --- | |||
| 01893 | PIRAMIL 5 MG | por tbl nob100x5mg | LSW | PL | |||
| 13475 | RAMIL 5 | por tblnob 30x5mg | ZEH | CZ | |||
| 13476 | RAMIL 5 | por tblnob 90x5mg | ZEH | CZ | |||
| 16367 | PIRAMIL 5 MG | por tbl nob 30x5mg | SZP | D | |||
| 16369 | PIRAMIL 5 MG | por tbl nob100x5mg | SZP | D | |||
| 23962 | AMPRILAN 5 | por tbl nob 30x5mg | KRK | SLO | |||
| 23964 | AMPRILAN 5 | por tbl nob 60x5mg | KRK | SLO | |||
| 23965 | AMPRILAN 5 | por tbl nob 90x5mg | KRK | SLO | |||
| 48754 | HARTIL 5 MG | portblnob 28x5mg | EGI | H | |||
| 81.6 | C09AA05 | ramipril nad 5 mg v jedné tabletě | p.o. | 2.50 | MG | 2,64 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 02023 | PIRAMIL 10 MG | por tbl nob 30x10mg | LSW | PL | |||
| --- | --- | --- | --- | --- | |||
| 02058 | PIRAMIL 10 MG | por tbl nob100x10mg | LSW | PL | |||
| 13477 | RAMIL 10 | por tblnob 30x10mg | ZEH | CZ | |||
| 13478 | RAMIL 10 | por tblnob 90x10mg | ZEH | CZ | |||
| 16383 | PIRAMIL 10 MG | por tbl nob 30x10mg | SZP | D | |||
| 16385 | PIRAMIL 10 MG | por tbl nob100x10mg | SZP | D | |||
| 23966 | AMPRILAN 10 | por tbl nob 30x10mg | KRK | SLO | |||
| 23968 | AMPRILAN 10 | por tbl nob 60x10mg | KRK | SLO | |||
| 23969 | AMPRILAN 10 | por tbl nob 90x10mg | KRK | SLO | |||
| 48755 | HARTIL 10 MG | portblnob 28x10mg | EGI | H | |||
| 81.7 | C09AA06 | quinapril do 15 mg v jedné tabletě včetně | p.o. | 15.00 | MG | 5,40 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 81.8 | C09AA06 | quinapril nad 15 mg v jedné tabletě | p.o. | 15.00 | MG | 3,78 | |
| 81.9 | C09AA07 | benazepril | p.o. | 7.50 | MG | 5,40 | |
| 81.10 | C09AA08 | cilazapril do 2,5 mg v 1 tbl včetně | p.o. | 2.50 | MG | 5,40 | |
| 81.11 | C09AA08 | cilazapril nad 2,5 mg v 1 tbl | p.o. | 2.50 | MG | 3,78 | |
| 81.12 | C09AA09 | fosinopril | p.o. | 15.00 | MG | 3,78 | |
| 81.13 | C09AA10 | trandolapril | p.o. | 2.00 | MG | 5,40 | |
| 81.14 | C09AA11 | spirapril | p.o. | 6.00 | MG | 5,40 | |
| 81.15 | C09AA12 | delapril | p.o. | 30.00 | MG | 5,40 | |
| 81.16 | C09AA13 | moexipril | p.o. | 15.00 | MG | 5,40 | |
| 81.17 | C09AA16 | imidapril do 5 mg v jedné tabletě včetně | p.o. | 5.00 | MG | 5,40 | |
| 81.18 | C09AA16 | imidapril nad 5 mg v jedné tabletě | p.o. | 5.00 | MG | 3,78 | |
| 82 | kombinace léčiv působících na renin-angiotenzinový systém s dalšími antihypertenzivy | ||||||
| 82.1 | C09BA01 | kaptopril a diuretika | p.o. | 1.00 | DF | 4,24 | |
| 82.2 | C09BA02 | enalapril a diuretika | p.o. | 1.00 | DF | 3,88 | |
| 55429 | ENAP-HL | por tbl nob 30 | KRK | SLO | |||
| --- | --- | --- | --- | --- | |||
| 66506 | ENAP-H | por tbl nob 30 | KRK | SLO | |||
| 82.3 | C09BA04 | perindopril a indapamid 2mg/0,625 mg | p.o. | 1.00 | DF | 2,98 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 82.4 | C09BA04 | perindopril a indapamid 4 mg/1,25 mg | p.o. | 1.00 | DF | 5,95 | |
| 82.5 | C09BA05 | ramipril s obsahem 2,5 mg a diuretikum s obsahem 12,5 mg v jedné tabletě | p.o. | 1.00 | DF | 5,86 | |
| 95275 | RAMIL H | por tbl nob 30 | ZEH | CZ | |||
| --- | --- | --- | --- | --- | |||
| 82.6 | C09BA05 | ramipril s obsahem 5 mg a diuretikum s obsahem 25 mg v jedné tabletě | p.o. | 1.00 | DF | 8,48 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 82.7 | C09BA06 | quinapril s obsahem 10 mg v jedné tabletě a diuretikum | p.o. | 1.00 | DF | 4,07 | |
| 82.8 | C09BA06 | quinapril s obsahem 20 mg v jedné tabletě a diuretikum s obsahem 12,5 mg | p.o. | 1.00 | DF | 5,50 | |
| 82.9 | C09BA06 | quinapril s obsahem 20 mg v jedné tabletě a diuretikum s obsahem 25 mg | p.o. | 1.00 | DF | 5,96 | |
| 82.10 | C09BA07 | benazepril a diuretika | p.o. | 1.00 | DF | 4,95 | |
| 82.11 | C09BA08 | cilazapril a diuretika | p.o. | 1.00 | DF | 8,02 | |
| 82.12 | C09BB05 | ramipril s obsahem 2,5 mg a felodipin s obsahem 2,5 mg v jedné tabletě | p.o. | 1.00 | DF | 7,85 | |
| 82.13 | C09BB05 | ramipril s obsahem 5 mg a felodipin s obsahem 5 mg v jedné tabletě | p.o. | 1.00 | DF | 12,45 | |
| 82.14 | C09BB10 | trandolapril a verapamil | p.o. | 1.00 | DF | 9,07 | |
| 82.15 | C09DA01 | losartan v kombinaci s thiazidy | p.o. | 1.00 | DF | 5,86 | |
| 97027 | LORISTA H | por tbl flm 28 | KRK | SLO | |||
| --- | --- | --- | --- | --- | |||
| 82.16 | C09DA03 | valsartan v kombinaci s thiazidy s obsahem 160 mg valsartanu a 12,5 mg hydrochlorothiazidu v jedné tabletě včetně | p.o. | 1.00 | DF | 8,02 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 82.17 | C09DA03 | valsartan v kombinaci s thiazidy s obsahem 160 mg valsartanu a 25 mg hydrochlorothiazidu v jedné tabletě včetně | p.o. | 1.00 | DF | 8,48 | |
| 82.18 | C09DA03 | valsartan v kombinaci s thiazidy s obsahem 80 mg valsartanu v jedné tabletě včetně | p.o. | 1.00 | DF | 5,86 | |
| 82.19 | C09DA06 | kandesartan v kombinaci s thiazidy s obsahem 16 mg kandesartanu v jedné tabletě | p.o. | 1.00 | DF | 8,02 | |
| 82.20 | C09DA06 | kandesartan v kombinaci s thiazidy s obsahem 8 mg kandesartanu v jedné tabletě | p.o. | 1.00 | DF | 5,86 | |
| 82.21 | C09DA07 | telmisartan v kombinaci s thiazidy s obsahem 40 mg telmisartanu v jedné tabletě | p.o. | 1.00 | DF | 5,86 | |
| 82.22 | C09DA07 | telmisartan v kombinaci s thiazidy s obsahem 80 mg telmisartanu v jedné tabletě | p.o. | 1.00 | DF | 8,02 | |
| 83 | léčiva ovlivňující systém renin-angiotenzin s výjimkou ACE-inhibitorů | ||||||
| 83.1 | C09CA01 | losartan do 50 mg v jedné tabletě včetně | p.o. | 50.00 | MG | 5,40 | |
| 10604 | LORISTA | por tblflm 28x50mg | KRK | SLO | |||
| --- | --- | --- | --- | --- | |||
| 10618 | LOZAP 12.5 | portblflm 30x12.5mg | ZEH | CZ | |||
| 10620 | LOZAP 50 | por tbl flm 30x50mg | ZEH | CZ | |||
| 13886 | LOZAP 12.5 ZENTIVA | portblflm 30x12.5mg | ZEH | SK | |||
| 13888 | LOZAP 12.5 ZENTIVA | portblflm 90x12.5mg | ZEH | SK | |||
| 13892 | LOZAP 50 ZENTIVA | por tbl flm 30x50mg | ZEH | SK | |||
| 13894 | LOZAP 50 ZENTIVA | por tbl flm 90x50mg | ZEH | SK | |||
| 15403 | LORISTA | por tblflm 56x50mg | KRK | SLO | |||
| 17963 | LOZAP 50 | por tbl flm 90x50mg | ZEH | CZ | |||
| 47610 | LORISTA | por tblflm 84x50mg | KRK | SLO | |||
| 95461 | LAKEA 50 MG | por tbl flm 30x50mg | LEK | SLO | |||
| 97062 | LOZAP 50 | por tbl flm 30x50mg | ZEH | CZ | |||
| 83.2 | C09CA01 | losartan nad 50 mg v jedné tabletě včetně | p.o. | 50.00 | MG | 3,78 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 83.3 | C09CA02 | eprosartan | p.o. | 600.00 | MG | 5,40 | |
| 83.4 | C09CA03 | valsartan do 80 mg v jedné tabletě včetně | p.o. | 80.00 | MG | 5,40 | |
| 83.5 | C09CA03 | valsartan nad 80 mg v jedné tabletě | p.o. | 80.00 | MG | 3,78 | |
| 83.6 | C09CA04 | irbesartan do 150 mg v jedné tabletě včetně | p.o. | 150.00 | MG | 7,51 | P |
| 83.7 | C09CA04 | irbesartan nad 150 mg v jedné tabletě | p.o. | 150.00 | MG | 5,98 | P |
Irbesartan je indikován v těchto případech:
- a) diabetická nefropatie již od fáze mikroalbuminurie,
- b) nediabetická nefropatie s proteinurií vyšší než 1 g/24 hodin u nemocných netolerujících ACE inhibitory.
| 83.8 | C09CA06 | kandesartan do 8 mg v jedné tabletě včetně | p.o. | 8.00 | MG | 5,40 | |
|---|---|---|---|---|---|---|---|
| 83.9 | C09CA06 | kandesartan nad 8 mg v jedné tabletě | p.o. | 8.00 | MG | 3,78 | |
| 83.10 | C09CA07 | telmisartan do 40 mg v jedné tabletě včetně | p.o. | 40.00 | MG | 5,40 | |
| 83.11 | C09CA07 | telmisartan nad 40 mg v jedné tabletě | p.o. | 40.00 | MG | 3,78 | |
| 83.12 | C09CA08 | olmesartan medoxomil do 20 mg v jedné tabletě včetně | p.o. | 20.00 | MG | 5,40 | |
| 83.13 | C09CA08 | olmesartan medoxomil nad 20 mg do 40 mg v jedné tabletě včetně | p.o. | 20.00 | MG | 3,78 | |
| 84 | hypolipidemika ze skupiny statinů | ||||||
| 84.1 | C10AA01 | simvastatin (do 10 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 4,89 | P |
| 10390 | SIMIREX 10 MG | por tbl flm 30x10mg | SYH | E | |||
| --- | --- | --- | --- | --- | |||
| 13499 | SIMGAL 10 MG | por tbl flm 84x10mg | IXP | CZ | |||
| 13827 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm 30x10mg | SBV | NL | |||
| 13830 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm 100x10mg | SBV | NL | |||
| 14733 | SIMVOR 10 MG | por tbl flm 30x10mg | IRI | IRL | |||
| 15697 | SIMIREX 10 MG | por tbl flm 60x10mg | SYH | E | |||
| 31844 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm 30x10mg | SYH | E | |||
| 31847 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm 100x10mg | SYH | E | |||
| 32578 | SIMGAL 10 MG | por tbl flm 28x10mg | IXP | CZ | |||
| 45336 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm 30x10mg | MCK | D | |||
| 45359 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm 100x10mg | MCK | D | |||
| 49919 | SIMVAX 10 | por tbl flm 28x10mg | SFS | D | |||
| 49923 | SIMVAX 10 | por tbl flm 28x10mg | SFS | D | |||
| 58136 | VASILIP 10 | tbl obd 28x10mg | KRK | SLO | |||
| 58773 | SIMVACARD 10 | tbl obd 28x10mg | ZEH | CZ | |||
| 66024 | SIMVOR 10MG | tbl obd 30x10mg | RXY | IND | |||
| 81479 | SIMVAX 10 | por tbl flm 28x10mg | GEA | DK | |||
| 95250 | VASILIP 10 | tbl obd 84x10mg | KRK | SLO | |||
| 97067 | SIMVAX 10 | por tbl flm 28x10mg | GEA | DK | |||
| 84.2 | C10AA01 | simvastatin (nad 10 do 20 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 7,82 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 10422 | SIMIREX 20 MG | por tbl flm 30x20mg | SYH | E | |||
| --- | --- | --- | --- | --- | |||
| 13701 | SIMGAL 20 MG | por tbl flm 84x20mg | IXP | CZ | |||
| 13843 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 30x20mg | SBV | NL | |||
| 13848 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 100x20mg | SBV | NL | |||
| 14734 | SIMVOR 20 MG | por tbl flm 30x20mg | IRI | IRL | |||
| 15073 | SIMIREX 20 MG | por tbl flm 60x20mg | SYH | E | |||
| 21719 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 100x20mg | MCK | D | |||
| 31851 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 30x20mg | SYH | E | |||
| 31856 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 100x20mg | SYH | E | |||
| 32579 | SIMGAL 20 MG | por tbl flm 28x20mg | IXP | CZ | |||
| 45752 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 30x20mg | MCK | D | |||
| 47731 | SIMVACARD 20 | tbl obd 84x20mg | ZEH | CZ | |||
| 49911 | SIMVAX 20 | por tbl flm 28x20mg | SFS | D | |||
| 49912 | SIMVAX 20 | por tbl flm 30x20mg | SFS | D | |||
| 49915 | SIMVAX 20 | por tbl flm 28x20mg | SFS | D | |||
| 49916 | SIMVAX 20 | por tbl flm 30x20mg | SFS | D | |||
| 58064 | VASILIP 20 | tbl obd 28x20mg | KRK | SLO | |||
| 58775 | SIMVACARD 20 | tbl obd 28x20mg | ZEH | CZ | |||
| 66026 | SIMVOR 20MG | tbl obd 30x20mg | RXY | IND | |||
| 81483 | SIMVAX 20 | por tbl flm 28x20mg | GEA | DK | |||
| 81484 | SIMVAX 20 | por tbl flm 30x20mg | GEA | DK | |||
| 95251 | VASILIP 20 | tbl obd 84x20mg | KRK | SLO | |||
| 97071 | SIMVAX 20 | por tbl flm 28x20mg | GEA | DK | |||
| 97072 | SIMVAX 20 | por tbl flm 30x20mg | GEA | DK | |||
| 84.3 | C10AA01 | simvastatin (nad 20 mg do 40mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 10,75 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 10459 | SIMIREX 40 MG | por tbl flm 30x40mg | SYH | E | |||
| --- | --- | --- | --- | --- | |||
| 13702 | SIMGAL 40 MG | por tbl flm 84x40mg | IXP | CZ | |||
| 13833 | SIMVASTATIN-RATIOPHARM 40 MG | por tbl flm 30x40mg | SBV | NL | |||
| 14735 | SIMVOR 40 MG | por tbl flm 30x40mg | IRI | IRL | |||
| 15070 | SIMREX 40 MG | por tbl flm 60x40mg | SYH | E | |||
| 17915 | SIMVACARD 40 | tbl obd 84x40mg | ZEH | CZ | |||
| 31859 | SIMVASTIN-RATIOPHARM 40 MG | por tbl flm 30x40mg | SYH | E | |||
| 32580 | SIMVAX 40 | por tbl flm 28x40mg | IXP | CZ | |||
| 42929 | VASILIP 40 | por tbl obd 28x40mg | KRK | SLO | |||
| 45535 | SIMVASTATIN-RATIOPHARM 40 MG | por tbl flm 30x40mg | MCK | D | |||
| 49901 | SIMVAX 40 | por tbl flm 28x40mg | SFS | D | |||
| 49902 | SIMVAX 40 | por tbl flm 30x40mg | SFS | D | |||
| 49905 | SIMVAX 40 | por tbl flm 28x40mg | SFS | D | |||
| 58777 | SIMVACARD 40 | tbl obd 28x40mg | ZEH | CZ | |||
| 66028 | SIMVOR 40MG | tbl obd 30x40mg | RXY | IND | |||
| 81487 | SIMVAX 40 | por tbl flm 28x40mg | GEA | DK | |||
| 81488 | SIMVAX 40 | por tbl flm 30x40mg | GEA | DK | |||
| 97075 | SIMVAX 40 | por tbl flm 28x40mg | GEA | DK | |||
| 84.4 | C10AA01 | simvastatin (nad 40 mg v jedné tabletě) | p.o. | 1.00 | DF | 15,05 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 84.5 | C10AA02 | lovastatin (do 20 mg v jedné tabletě včetně | p.o. | 1.00 | DF | 4,40 | P |
| 01300 | APO-LOVASTATIN 20 | tbl 30x20mg | APT | CND | |||
| --- | --- | --- | --- | --- | |||
| 15397 | APO-LOVASTATIN 20 | tbl 100x20mg | CMG | IRL | |||
| 15398 | APO-LOVASTATIN 20 | tbl 30x20mg | CMG | IRL | |||
| 16572 | APO-LOVASTATIN 20 | tbl 100x20mg | KAT | NL | |||
| 16573 | APO-LOVASTATIN 20 | tbl 30x20mg | KAT | NL | |||
| 53286 | APO-LOVASTATIN 20 | tbl 100x20mg | APT | CND | |||
| 53506 | MEDOSTATIN 20MG | tbl 30x20mg | MOE | CY | |||
| 53507 | MEDOSTATIN 20MG | tbl 100x20mg | MOE | CY | |||
| 58799 | HOLETAR 20 | tbl 30x20mg | KRK | SLO | |||
| 84.6 | C10AA02 | lovastatin (nad 20 mg v jedné tabletě do 40 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 6,60 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01254 | APO-LOVASTATIN 40 | tbl 30x40mg | APT | CND | |||
| --- | --- | --- | --- | --- | |||
| 15394 | APO-LOVASTATIN 40 | tbl 100x40mg | CMG | IRL | |||
| 15396 | APO-LOVASTATIN 40 | tbl 30x40mg | CMG | IRL | |||
| 16575 | APO-LOVASTATIN 40 | tbl 100x40mg | KAT | NL | |||
| 16577 | APO-LOVASTATIN 40 | tbl 30x40mg | KAT | NL | |||
| 53287 | APO-LOVASTATIN 40 | tbl 100x40mg | APT | CND | |||
| 84.7 | C10AA03 | pravastatin (do 10 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 4,69 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 84.8 | C10AA03 | pravastatin (nad 10 mg do 20 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 7,04 | P |
| 84.9 | C10AA03 | pravastatin (nad 20 mg v jedné tabletě) | p.o. | 1.00 | DF | 10,55 | P |
| 84.10 | C10AA04 | fluvastatin (do 20 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 4,69 | P |
| 84.11 | C10AA04 | fluvastatin (nad 20 mg do 40 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 7,04 | P |
| 84.12 | C10AA04 | fluvastatin (nad 40 MG v jedné tabletě) | p.o. | 1.00 | DF | 16,47 | P |
| 84.13 | C10AA05 | atorvastatin (do 10 MG včetně v jedné tabletě) | p.o. | 1.00 | DF | 8,31 | P |
| 19590 | TORVACARD 10 | por tbl flm 30x10mg | ZEH | CZ | |||
| --- | --- | --- | --- | --- | |||
| 19591 | TORVACARD 10 | por tbl flm 90x10mg | ZEH | CZ | |||
| 20165 | TULIP 10 MG | por tbl flm 30x10mg | LEK | SLO | |||
| 42051 | TULIP LEK 10 MG POTAHOVANÉ TBL | por tbl flm30x10mg | LEK | SLO | |||
| 49004 | ATORIS 10 | por tbl flm30x10mg | KRK | SLO | |||
| 49005 | ATORIS 10 | por tbl flm 60x10mg | KRK | SLO | |||
| 49006 | ATORIS 10 | por tbl flm 90x10mg | KRK | SLO | |||
| 84.14 | C10AA05 | atorvastatin (nad 10 MG do 20 MG v jedné tabletě včetně) | p.o. | 1.00 | DF | 10,75 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 19592 | TORVACARD 20 | por tbl flm 30x20mg | ZEH | CZ | |||
| --- | --- | --- | --- | --- | |||
| 19593 | TORVACARD 20 | por tbl flm 90x20mg | ZEH | CZ | |||
| 20166 | TULIP 20 MG | por tbl flm 30x20mg | LEK | SLO | |||
| 42056 | TULIP LEK 20 MG POTAHOVANÉ TBL | por tblflm30x20mg | LEK | SLO | |||
| 49007 | ATORIS 20 | por tbl flm 30x20mg | KRK | SLO | |||
| 49008 | ATORIS 20 | por tbl flm 60x20mg | KRK | SLO | |||
| 49009 | ATORIS 20 | por tbl flm 90x20mg | KRK | SLO | |||
| 84.15 | C10AA05 | atorvastatin (nad 20 MG do 40 MG v jedné tabletě včetně) | p.o. | 1.00 | DF | 14,17 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 84.16 | C10AA05 | atorvastatin (nad 40 MG v jedné tabletě) | p.o. | 1.00 | DF | 28,34 | P |
| 84.17 | C10AA07 | rosuvastatin (do 10 MG v jedné tabletě včetně) | p.o. | 1.00 | DF | 18,82 | P |
| 84.18 | C10AA07 | rosuvastatin (nad 10 MG do 20 MG v jedné tabletě včetně) | p.o. | 1.00 | DF | 28,23 | P |
| 84.19 | C10AA07 | rosuvastatin (nad 20 MG do 40 MG v jedné tabletě včetně) | p.o. | 1.00 | DF | 42,36 | P |
- A) Léčba atorvastatinem (10 a 20mg), simvastatinem (10,20 a 40mg), fluvastatinem ( 20 a 40mg) a lovastatinem (20,40 a80mg) a pravastatinem ( 20 a 40mg) je indikována u nemocných s hypercholesterolémií a manifestní aterosklerózou či diabetem nebo v případě, že celkové desetileté kardiovaskulární riziko úmrtí nemocného dle systému SCORE (platného pro ČR) je větší než 5% (toto riziko musí být při iniciaci léčby uvedeno ve zdravotnické dokumentaci). Pro účinnost léčby je nejvýznamnějším ukazatelem hodnota LDL-cholesterolu, jejíž cílová hodnota je stanovena na 3,0mmol/l. Kombinaci hypolipidemik může indikovat a předepisovat pouze kardiolog, internista, lékař lipidologické poradny a diabetolog.
- B) Léčba atorvastatinem (v dávce vyšší než 20mg), fluvastatinem (v dávce vyšší než 40mg) či rosuvastatinem je předepisována kardiologem, internistou, diabetologem,angiologem nebo lékařem lipidologické poradny u nemocných s hypercholesterolémií a manifestní aterosklerózou či diabetem nebo v případě, že celkové desetileté kardiovaskulární riziko úmrtí nemocného dle systému SCORE (platného pro ČR) je větší než 5% a kdy nelze dosáhnout cílových hodnot (LDL ≤ 3,0mmol/l) statiny uvedenými v A) nebo kdy statiny uvedené v bodě A) nelze použít.
| 85 | hypolipidemika ze skupiny fibratů a ostatních skupin | ||||||
|---|---|---|---|---|---|---|---|
| 85.1 | C10AB | klofibrát (etofylin) | p.o. | 0.50 | GM | 4,22 | |
| 85.2 | C10AB02 | bezafibrát | p.o. | 0.60 | GM | 6,03 | |
| 85.3 | C10AB04 | gemfibrozil | p.o. | 1.20 | GM | 6,03 | |
| 85.4 | C10AB05 | fenofibrát | p.o. | 0.30 | GM | 6,03 | |
| 85.5 | C10AB05 | fenofibrát (mikronisované lékové formy) | p.o. | 1.00 | DF | 6,67 | |
| 04143 | APO-FENO | por cpsdur 30x200mg | APT | CND | |||
| --- | --- | --- | --- | --- | |||
| 04145 | APO-FENO | por cpsdur100x200mg | APT | CND | |||
| 13337 | LIPOHEXAL 250 RETARD | por cps ret60x250mg | SFS | D | |||
| 13338 | LIPOHEXAL 250 RETARD | por cps ret90x250mg | SFS | D | |||
| 13596 | LIPIREX 267 MG | por cps dur30x267mg | SGY | B | |||
| 13598 | LIPIREX 267 MG | por cps dur60x267mg | SGY | B | |||
| 14316 | FENOFIX 200 | por cps dur90x200mg | IXP | CZ | |||
| 15501 | APO-FENO | por cps dur30x200mg | CMG | IRL | |||
| 15503 | APO-FENO | por cpsdur100x200mg | CMG | IRL | |||
| 16597 | APO-FENO | por cps dur30x200mg | KAT | NL | |||
| 16599 | APO-FENO | por cpsdur100x200mg | KAT | NL | |||
| 32652 | FEBIRA 200 | por cps dur30x200mg | ZEH | SK | |||
| 32653 | FEBIRA 200 | por cps dur60x200mg | ZEH | SK | |||
| 32654 | FEBIRA 200 | por cps dur90x200mg | ZEH | SK | |||
| 32722 | FENOFIX 200 | por cps dur30x200mg | IXP | CZ | |||
| 41797 | LIPIREX 200MG | por cps dur60x200mg | SGY | B | |||
| 56460 | LIPIREX 200MG | por cps dur30x200mg | SGY | B | |||
| 58769 | LIPOHEXAL 250 RETARD | por cps ret30x250mg | SFS | D | |||
| 58770 | LIPOHEXAL 250 RETARD | por cpsret 100x250mg | SFS | D | |||
| 99839 | LIPIREX S 160 MG | por cps dur60x160mg | SGY | B | |||
| 85.6 | C10AB05 | fenofibrát (supramikronisované lékové formy) | p.o. | 1.00 | DF | 8,36 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 85.7 | C10AB08 | ciprofibrát | p.o. | 0.10 | GM | 6,67 | |
| 85.8 | C10AC01 | cholestyramin | p.o. | 14.00 | GM | 30,38 | P |
| 85.9 | C10AC02 | colestipol | p.o. | 20.00 | GM | 30,38 | P |
Léčbu cholestyraminem a colestipolem předepisuje gastroenterolog, kardiolog, internista, nebo lékař pracující v poradnách pro léčbu poruch metabolismu lipidů:
- a) u pacientů s hyperlipoproteinemií s vysokou hladinou cholesterolu,
- b) u pacientů s pruritem při biliární cirhóze.
| 85.10 | C10AD06 | acipimox | p.o. | 500.00 | MG | 10,35 | |
|---|---|---|---|---|---|---|---|
| 85.11 | C10AX09 | ezetimib | p.o. | 10.00 | MG | 44,96 | P |
Ezetimib je určen pro kombinační léčbu se statiny (tj. je indikován v případě použití ve druhé volbě). Léčbu ezetimibem předepisuje specialista (kardiolog, internista, diabetolog nebo lékař lipidologické poradny) u nemocných s těžkou rezistentní hyperlipoproteinémií (familiární hypercholesterolémie), u kterých nevedla léčba vyššími dávkami statinů, trvající alespoň 6 měsíců k dosažení cílových hodnot LDLcholesterolu (LDL ≤ 3,0mmol/l). Za vyšší dávku statinů je považováno 40 mg simvastatinu, 40 mg atorvastatinu, 80 mg fluvastatinu a lovastatinu, 20 mg rosuvastatinu. V kombinaci s ezetimibem jsou indikovány základní dávky statinů (tj. do 40 mg simvastatinu a atorvastatinu, do 80 mg fluvastatinu a lovastatinu a do 20 mg rosuvastatinu). Pokud kombinační léčba není účinná (nebylo dosaženo výše uvedených cílových hodnot LDL cholesterolu) po 3 měsících léčby, je ezetimib vysazen.
Ezetimib je dále předepisován uvedenými specialisty u nemocných, u kterých vedla léčba statiny k významným a řádně dokumentovaným nežádoucím účinkům: elevaci aminotransferáz na více než trojnásobek a CK na více než pětinásobek normálních hodnot. Za neúčinnost léčby je považováno, pokud po 3 měsících léčby nedojde k aditivnímu poklesu LDL cholesterolu alespoň o 10% ve srovnání s monoterapií statinem.
| 86 | Ostatní léčiva používaná u nemocí kardiovaskulárního systému | ||||||
|---|---|---|---|---|---|---|---|
| 86.1 | C01CX08 | levosimendan | parent. | 11.00 | MG | 19 819,64 | H |
| 86.2 | C01DA02 | glycerol trinitrát | parent. | 2.50 | MG | 12,69 | H |
| 04307 | NITRO POHL INFUS. | inf 10x10ml/10mg | PLB | D | |||
| --- | --- | --- | --- | --- | |||
| 86.3 | C01DA08 | isosorbid dinitrát | parent. | 20.00 | MG | 121,15 | H |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 86.4 | C01DX03 | oxifedrin | parent. | 40.00 | MG | 13,47 | H |
| 86.5 | C01DX12 | molsidomin | parent. | 6.00 | MG | 102,99 | H |
| 87 | antimykotika k lokálnímu použití ze skupiny antibiotik, imidazolových a triazolových derivátů | ||||||
| 87.1 | D01AA01 | nystatin | lok. | 1.00 | GM | 2,62 | |
| 87.2 | D01AA02 | natamycin | lok. | 1.00 | GM | 1,92 | |
| 87.3 | D01AC01 | klotrimazol do 20 g včetně | lok. | 1.00 | GM | 1,73 | |
| 65484 | CLOTRIMAZOL AL 1% | crm 1x20gm 1% | APA | D | |||
| --- | --- | --- | --- | --- | |||
| 87.4 | D01AC01 | klotrimazol nad 20 g | lok. | 1.00 | GM | 1,49 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 86397 | CLOTRIMAZOL AL 1% | crm 1x50gm 1% | APA | D | |||
| --- | --- | --- | --- | --- | |||
| 87.5 | D01AC01 | klotrimazol tekuté lékové formy | lok. | 1.00 | GM | 2,48 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 87.6 | D01AC02 | mikonazol | lok. | 1.00 | GM | 1,73 | |
| 87.7 | D01AC03 | ekonazol (lékové formy tekuté, lipogelu a pasty) | lok. | 1.00 | GM | 3,09 | |
| 87.8 | D01AC03 | ekonazol lékové formy krému | lok. | 1.00 | GM | 1,73 | |
| 87.9 | D01AC05 | isokonazol | lok. | 1.00 | ML | 1,73 | |
| 87.10 | D01AC08 | ketokonazol | lok. | 1.00 | GM | 1,73 | |
| 87.11 | D01AC10 | bifonazol | lok. | 1.00 | GM | 2,43 | |
| 87.12 | D01AC11 | oxikonazol | lok. | 1.00 | GM | 2,43 | |
| 87.13 | D01AC12 | fenticonazol | lok. | 1.00 | GM | 1,73 | |
| 87.14 | D01AC14 | sertakonazol | lok. | 1.00 | GM | 2,43 | |
| 87.15 | G01AF18 | flutrimazol, lékové forma gelu | lok. | 1.00 | GM | 2,99 | |
| 87.16 | G01AF18 | flutrimazol, lékové forma krém a spray | lok. | 1.00 | GM | 4,59 | |
| 87.17 | D01AC20 | kombinace | lok. | 1.00 | GM | 1,73 | |
| 87.18 | D01AC51 | clotrimazol/urea | lok. | 1.00 | GM | 1,73 | |
| 87.19 | D01AC60 | bifonazol, kombinace | lok. | 1.00 | GM | 13,11 | P |
Léčbu předepisuje dermatolog u onychomykóz, doložených kultivačním vyšetřením.
| 88 | Ostatní antimykotika k lokálnímu použití | ||||||
|---|---|---|---|---|---|---|---|
| 88.1 | D01AE | jiná antimykotika k zevnímu použití | lok. | 1.00 | ML | 0,76 | |
| 88.2 | D01AE | naftini hydrochlorid | lok. | 1.00 | GM | 2,86 | |
| 88.3 | D01AE04 | kyselina undecylenová | lok. | 1.00 | GM | 0,95 | |
| 00871 | MYKOSEPTIN | ung 1x30gm | ZEH | CZ | |||
| --- | --- | --- | --- | --- | |||
| 88.4 | D01AE14 | ciclopirox | lok. | 1.00 | GM | 3,70 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 88.5 | D01AE15 | terbinafin | lok. | 1.00 | GM | 3,70 | |
| 88.6 | D01AE16 | amorolfin | lok. | 1.00 | MG | 3,27 | |
| 88.7 | D01AE18 | tolnaftat | lok. | 1.00 | GM | 1,79 | |
| 88.8 | D01AE19 | tolciklát | lok. | 1.00 | GM | 1,79 | |
| 88.9 | D01AE20 | kombinace antimykotik (ostatní kombinace) | lok. | 1.00 | GM | 0,63 | |
| 88.10 | D01AE20 | kombinace antimykotik (tolnaftat/cetrimid) | lok. | 1.00 | GM | 1,79 | |
| 89 | emolliencia a protektiva | ||||||
| 89.1 | D02AB | přípravky obsahující oxid zinečnatý (do 120 g v jednom balení včetně) | lok. | 1.00 | GM | 0,50 | |
| 54249 | SUSPENSIO ZINCI OXYDATI HERBAC. | sus 1x100gm | HEO | CZ | |||
| --- | --- | --- | --- | --- | |||
| 89.2 | D02AC | měkký parafin a tukové produkty (do 250 gm v 1 balení včetně) | lok. | 1.00 | GM | 0,58 | L/DER,PED |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 89.3 | D02AC | měkký parafin a tukové produkty (do 250 ml v 1 balení včetně) - tekuté lékové formy | lok. | 1.00 | ML | 0,58 | L/DER,PED |
| 89.4 | D02AC | měkký parafin a tukové produkty (nad 250 gm v 1 balení) | lok. | 1.00 | GM | 0,42 | L/DER,PED |
| 89.5 | D02AC | měkký parafin a tukové produkty (nad 250 ml v 1 balení) - tekuté lékové formy | lok. | 1.00 | ML | 0,42 | L/DER,PED |
| 89.6 | D02AC | měkký parafin s polydekanolem (do 250 ml v 1 balení včetně) | lok. | 1.00 | ML | 0,64 | L/DER,PED |
| 89.7 | D02AC | měkký parafin s polydekanolem (nad 250 ml v 1 balení) | lok. | 1.00 | ML | 0,46 | L/DER,PED |
| 89.8 | D02AE01 | měkký parafin a tukové produkty s obsahem močoviny - tekuté lékové formy | lok. | 1.00 | ML | 0,45 | L/DER,PED |
| 89.9 | D02AE01 | urea | lok. | 1.00 | GM | 0,45 | L/DER,PED |
| 89.10 | D02AE51 | kombinace kyseliny salicylové s ureou | lok. | 1.00 | GM | 0,98 | |
| 89.11 | D02AX | jiná emolliencia a protektiva (do 50 g v balení včetně) | lok. | 1.00 | GM | 1,67 | |
| 89.12 | D02AX | jiná emolliencia a protektiva (nad 50 g v balení) | lok. | 1.00 | GM | 0,63 | |
| 90 | léčiva pro léčbu ran a vředů | ||||||
| 90.1 | D03AX | jiná léčiva podporující tvorbu jizev (chlorofyl) | lok. | 1.00 | ML | 0,48 | |
| 90.2 | D03AX | jiná léčiva podporující zajizvení (kombinace celulosa + karboxycelulosa, na obsah karboxycelulosy) | lok. | 1.00 | GM | 15,05 | |
| 90.3 | D03AX | jiná léčiva podporující zajizvení (zinci hyaluronas -lékové formy gelu) | lok. | 1.00 | GM | 1,39 | |
| 90.4 | D03AX | jiná léčiva podporující zajizvení (zinci hyaluronas -lékové formy roztoku) | lok. | 1.00 | ML | 3,82 | |
| 90.5 | D03AX02 | dextranomer | lok. | 1.00 | GM | 3,82 | |
| 90.6 | D03BA | proteolytické enzymy (chymotrypsin) | lok. | 1.00 | GM | 77,48 | P |
| 90.7 | D03BA | proteolytické enzymy (plasmin/deoxiribonukleáza) | lok. | 1.00 | GM | 13,70 | P |
| 02594 | FIBROLAN MAST | ung 1x25gm | PDA | F | |||
| --- | --- | --- | --- | --- | |||
| 48200 | FIBROLAN MAST | ung 1x25gm | PPO | F | |||
| 90.8 | D03BA | proteolytické enzymy (trypsin/chymotrypsin) | lok. | 1.00 | GM | 28,19 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 90.9 | D03BA52 | proteolytické enzymy (kolagenáza - do 10 GM v jednom balení včetně) | lok. | 1.00 | GM | 18,15 | P |
| 90.10 | D03BA52 | proteolytické enzymy (kolagenáza - nad 10 GM v jednom balení) | lok. | 1.00 | GM | 16,24 | P |
Léčbu proteolytickými enzymy předepisuje chirurg, ortoped, gynekolog, otorhinolaryngolog nebo dermatolog k:
- a) léčbě bércových vředů,
- b) léčbě nekrotických poúrazových nebo pooperačních ran,
- c) ošetřování nekrotických ran a dekubitů.
| 91 | Antipsoriatika | ||||||
|---|---|---|---|---|---|---|---|
| 91.1 | D05AA | dehty | lok. | 1.00 | GM | 0,71 | |
| 55290 | UNGUENTUM ICHTHAMOLI 10% MVM | drm ung 1x100gm | MVM | CZ | |||
| --- | --- | --- | --- | --- | |||
| 83870 | UNGUENTUM ICHTHAMOLI 10% MVM | drm ung 1x1kg | MVM | CZ | |||
| 85950 | SUSPENSIO VIŠNĚVSKI+PICE LIQUID | sus 1x1000gm | HEO | CZ | |||
| 91.2 | D05AA | dehty (odbarvený dehet) | lok. | 1.00 | GM | 1,14 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 91.3 | D05AC01 | dithranol | lok. | 1.00 | GM | 3,82 | |
| 91.4 | D05AD02 | methoxalen (0,15 % koncentrace) | lok. | 1.00 | ML | 3,96 | |
| 90618 | OXSORALEN | liq 1x50ml 0.15% | GER | A | |||
| --- | --- | --- | --- | --- | |||
| 91.5 | D05AX02 | calcipotriol | lok. | 1.00 | GM | 8,80 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 91.6 | D05AX03 | calcitriol | lok. | 1.00 | GM | 8,80 | P |
| 91.7 | D05AX04 | tacalcitol | lok. | 1.00 | GM | 17,59 | P |
| 91.8 | D05AX05 | tazaroten | lok. | 1.00 | GM | 17,59 | P |
| 91.9 | D05AX52 | kalcipotriol, kombinace | lok. | 1.00 | GM | 9,68 | P |
Léčbu deriváty vitaminu D včetně kombinací v lokálních lékových formách předepisuje dermatolog k:
léčbě torpidních lokalizovaných forem psoriázy nereagující na standardní léčbu v množství maximálně 100 g týdně.
| 91.10 | D05BA02 | methoxalen | p.o. | 10.00 | MG | 3,72 | L/DER |
|---|---|---|---|---|---|---|---|
| 03733 | OXSORALEN | cps 50x10mg | GER | A | |||
| --- | --- | --- | --- | --- | |||
| 91.11 | D05BB01 | etretinát | p.o. | 35.00 | MG | 71,36 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 91.12 | D05BB02 | acitretin | p.o. | 35.00 | MG | 71,36 | P |
Léčbu etretinátem a acitretinem předepisuje dermatolog
- a) léčba těžkých generalizovaných forem psoriázy a u všech forem pustulózní psoriázy nereagující na jinou léčbu
Čtení tohoto dokumentu nenahrazuje čtení příslušného vydání Sbírky zákonů. Neneseme odpovědnost za případné nepřesnosti vyplývající z převodu originálu do tohoto formátu.
Tento text je zveřejněn za vlastních podmínek opětovného použití zdroje e-Sbírka, nikoli pod licencí Legalize ani pod licencí volného díla.
e-Sbírka
volné dílo (úřední díla podle § 3 písm. a) zákona č. 121/2000 Sb., autorského zákona)